Brought to you by 
Rapid Micro Biosystems gets $60mm in equity financing
04 May 2018
Executive Summary
Rapid Micro Biosystems Inc. (rapid microbial detection technology) raised $60mm in a late-stage equity financing co-led by first-time backers Bain Capital Life Sciences and Xeraya Capital, which were joined by another new investor Asahi Kasei Medical and returning shareholders Longitude Capital, Quaker Partners, TVM Capital, and Richard K. Mellon. According to the Form D, 11 investors participated. The company will use the funds for worldwide commercial expansion, operations, and product innovation.
Deal Industry
- In Vitro Diagnostics
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Rapid Micro Biosystems gets $60mm in equity financing
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice